ID: ALA2381009

Max Phase: Preclinical

Molecular Formula: C18H21ClN2O3

Molecular Weight: 348.83

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CCC[C@@H]1N1C(=O)CC(=O)N(CCc2cccc(Cl)c2)C1=O

Standard InChI:  InChI=1S/C18H21ClN2O3/c1-12-4-2-7-15(12)21-17(23)11-16(22)20(18(21)24)9-8-13-5-3-6-14(19)10-13/h3,5-6,10,12,15H,2,4,7-9,11H2,1H3/t12-,15+/m1/s1

Standard InChI Key:  JGCNZILWZBJOMI-DOMZBBRYSA-N

Associated Targets(non-human)

CACNA1C Voltage-gated L-type calcium channel alpha-1C subunit (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1d Voltage-gated L-type calcium channel alpha-1D subunit (336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 348.83Molecular Weight (Monoisotopic): 348.1241AlogP: 3.25#Rotatable Bonds: 4
Polar Surface Area: 57.69Molecular Species: ACIDHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.00CX Basic pKa: CX LogP: 3.51CX LogD: 1.18
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: -0.79

References

1. Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB..  (2013)  Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.,  56  (11): [PMID:23651412] [10.1021/jm4005048]

Source